74 related articles for article (PubMed ID: 27785808)
1. A model of BCR-FGFR1 driven human AML in immunocompromised mice.
Cowell JK; Qin H; Chang CS; Kitamura E; Ren M
Br J Haematol; 2016 Nov; 175(3):542-545. PubMed ID: 27785808
[No Abstract] [Full Text] [Related]
2. Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.
Ren M; Qin H; Wu Q; Savage NM; George TI; Cowell JK
Int J Cancer; 2016 Aug; 139(4):836-40. PubMed ID: 27005999
[TBL] [Abstract][Full Text] [Related]
3. A case of acute myelogenous leukaemia characterised by the BCR-FGFR1 translocation.
Matikas A; Tzannou I; Oikonomopoulou D; Bakiri M
BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23519513
[TBL] [Abstract][Full Text] [Related]
4. Distinct signaling programs associated with progression of FGFR1 driven leukemia in a mouse model of stem cell leukemia lymphoma syndrome.
Silva J; Chang CS; Hu T; Qin H; Kitamura E; Hawthorn L; Ren M; Cowell JK
Genomics; 2019 Dec; 111(6):1566-1573. PubMed ID: 30439482
[TBL] [Abstract][Full Text] [Related]
5. FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model.
Qin H; Wu Q; Cowell JK; Ren M
Haematologica; 2016 Mar; 101(3):e91-4. PubMed ID: 26589915
[No Abstract] [Full Text] [Related]
6. Dysregulated signaling pathways in the development of CNTRL-FGFR1-induced myeloid and lymphoid malignancies associated with FGFR1 in human and mouse models.
Ren M; Qin H; Kitamura E; Cowell JK
Blood; 2013 Aug; 122(6):1007-16. PubMed ID: 23777766
[TBL] [Abstract][Full Text] [Related]
7. A case with ZNF198-FGFR1 gene rearrangement presenting as acute eosinophil myeloid leukemia.
Chao H; Zhou M; Zhang R
Chin Med J (Engl); 2015 Jan; 128(1):131-2. PubMed ID: 25563327
[No Abstract] [Full Text] [Related]
8. Re: Acute myeloid leukemia associated with FGFR1 abnormalities.
Yang JJ; Oh SH; Meyer C; Marschalek R; Park TS
Int J Hematol; 2013 Jul; 98(1):139-40. PubMed ID: 23743951
[No Abstract] [Full Text] [Related]
9. Reply to the letter by Yang et al. RE: acute myeloid leukemia associated with FGFR1 abnormalities.
Kim Y; Lee H; Kim M
Int J Hematol; 2013 Jul; 98(1):141. PubMed ID: 23736983
[No Abstract] [Full Text] [Related]
10. A novel fusion of SQSTM1 and FGFR1 in a patient with acute myelomonocytic leukemia with t(5;8)(q35;p11) translocation.
Nakamura Y; Ito Y; Wakimoto N; Kakegawa E; Uchida Y; Bessho M
Blood Cancer J; 2014 Dec; 4(12):e265. PubMed ID: 25501022
[No Abstract] [Full Text] [Related]
11. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.
Patnaik MM; Gangat N; Knudson RA; Keefe JG; Hanson CA; Pardanani A; Ketterling RP; Tefferi A
Am J Hematol; 2010 Apr; 85(4):238-42. PubMed ID: 20143402
[TBL] [Abstract][Full Text] [Related]
12. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
[TBL] [Abstract][Full Text] [Related]
13. Activation of FGFR1beta signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells.
Karajannis MA; Vincent L; Direnzo R; Shmelkov SV; Zhang F; Feldman EJ; Bohlen P; Zhu Z; Sun H; Kussie P; Rafii S
Leukemia; 2006 Jun; 20(6):979-86. PubMed ID: 16598308
[TBL] [Abstract][Full Text] [Related]
14. Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model.
Sontakke P; Carretta M; Jaques J; Brouwers-Vos AZ; Lubbers-Aalders L; Yuan H; de Bruijn JD; Martens AC; Vellenga E; Groen RW; Schuringa JJ
Leukemia; 2016 Oct; 30(10):2064-2073. PubMed ID: 27125308
[TBL] [Abstract][Full Text] [Related]
15. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
16. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
Agelopoulos K; Richter GH; Schmidt E; Dirksen U; von Heyking K; Moser B; Klein HU; Kontny U; Dugas M; Poos K; Korsching E; Buch T; Weckesser M; Schulze I; Besoke R; Witten A; Stoll M; Köhler G; Hartmann W; Wardelmann E; Rossig C; Baumhoer D; Jürgens H; Burdach S; Berdel WE; Müller-Tidow C
Clin Cancer Res; 2015 Nov; 21(21):4935-46. PubMed ID: 26179511
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of fibroblast growth factor receptor 1 in endometriosis and its correlation with endometriosis-related dysmenorrhea and recurrence.
Zhao L; Yang H; Xuan Y; Luo Z; Lin Q; Zhao J; Ren N; Zhou S; Zhao X
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():117-24. PubMed ID: 25500535
[TBL] [Abstract][Full Text] [Related]
18. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia.
Hassan A; Durlacher K; Silver J; Naveh-Many T; Levi R
Am J Physiol Renal Physiol; 2016 Feb; 310(3):F217-21. PubMed ID: 26311115
[TBL] [Abstract][Full Text] [Related]
19. Myeloid and lymphoid neoplasms with FGFR1 abnormalities: diagnostic and therapeutic challenges.
Savage NM; Johnson RC; Gotlib J; George TI
Am J Hematol; 2013 May; 88(5):427-30. PubMed ID: 22886804
[No Abstract] [Full Text] [Related]
20. Association of a murine leukaemia stem cell gene signature based on nucleostemin promoter activity with prognosis of acute myeloid leukaemia in patients.
Ali MA; Naka K; Yoshida A; Fuse K; Kasada A; Hoshii T; Tadokoro Y; Ueno M; Ohta K; Kobayashi M; Takahashi C; Hirao A
Biochem Biophys Res Commun; 2014 Jul; 450(1):837-43. PubMed ID: 24960197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
